# Limited Competition: Competing Revisions to Support Clinical Trials in Somatic Cell Genome Editing (U19 Clinical Trial Required)

Source: https://welltoldgrants.com/grants/rfa-rm-24-008-limited-competition-competing-revisions-to-support-clinical/  
Official notice: https://www.grants.gov/search-results-detail/357306

> National Institutes of Health offered grants to state and local governments and tribes. Applications closed on February 13, 2026.

| Field | Value |
|---|---|
| Opportunity number | RFA-RM-24-008 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | February 13, 2026 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.310 |

## Who can apply

- Independent school districts
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Others (see text field entitled "Additional Information on Eligibility" for clarification)

Other Eligible Applicants include the following: Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

## What the grant funds

The purpose of this Notice of Funding Opportunity (NOFO) is to solicit competitive revision (formerly known as competitive supplement) applications from awardees with active U19 awards funded under RFA-RM-22-015 as part ofthe NIH Somatic Cell Genome Editing program, in order to expand the scope of the original award to allow first in human genome editing clinical trials using the therapeutic clinical candidates developed through the U19 award. RFA-RM-22-015 did not allow a clinical trial, whereas the present NOFO (RFA-RM-24-008) requires a clinical trial.

## Questions people ask

### Is RFA-RM-24-008 still open?

No. It closed on February 13, 2026.

### Who can apply for Limited Competition: Competing Revisions to Support Clinical Trials in Somatic Cell Genome Editing (U19 Clinical Trial Required)?

National Institutes of Health accepted applications from state and local governments and tribes. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Limited Competition: Competing Revisions to Support Clinical Trials in Somatic Cell Genome Editing (U19 Clinical Trial Required)?

Closed February 13, 2026. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### Who has been funded under RFA-RM-24-008?

NIH RePORTER lists 1 project funded under RFA-RM-24-008 in fiscal 2026, at 1 institution.

### Who has won Trans-NIH Research Support grants before?

The largest recipients over five fiscal years were Duke University, The Leland Stanford Junior University, University of Pittsburgh - of the Commonwealth System of Higher Education. The program made 4,433 awards worth $5.9 billion in that time.